Keywords: Other Neurodegeneration, Neurodegeneration, Huntington's Disease; DTI-ALPS; Biomarkers
Motivation: Huntington's disease causes neurodegeneration linked to toxic protein buildup. Identifying glymphatic dysfunction as a biomarker could improve detection, informing interventions targeting the glymphatic system.
Goal(s): This study investigates whether glymphatic dysfunction, indicated by lower diffusion tensor image analysis along the perivascular space (DTI-ALPS), is present in HD patients and correlates with symptoms.
Approach: Using DTI-ALPS, a non-invasive imaging technique, we assessed glymphatic function in 287 subjects, comparing healthy, pre-manifest, and manifest HD groups, and correlating scores with motor and cognitive performance.
Results: HD patients exhibit lower DTI-ALPS scores, manifest HD showing the most decline. Lower ALPS correlated with greater motor and cognitive impairments.
Impact: This research positions DTI-ALPS reduction as a promising biomarker for glymphatic dysfunction in HD, correlating with disease severity and symptoms. DTI-ALPS could enhance understanding of HD pathogenesis, support clinical monitoring of glymphatic dysfunction, and potentially inform targeted interventions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords